[January 18, 2013]

Research and Markets: Heart Transplantation - Pipeline Review, H2 2012 Considers Companies and Universities Involved

Research and Markets (http://www.researchandmarkets.com/research/9j8p73/heart) has announced the addition of Global Markets Direct's new report "Heart Transplantation - Pipeline Review, H2 2012" to their offering.

Heart Transplantation - Pipeline Review, H2 2012

Summary

Global Markets Direct's, 'Heart Transplantation - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Heart Transplantation, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Heart Transplantation. Heart Transplantation - Pipelne Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC (News - Alert) filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Heart Transplantation.

- A review of the Heart Transplantation products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Heart Transplantation pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

Alexion Pharmaceuticals, Inc.

Portola Pharmaceuticals, Inc.

NasVax Ltd.

For more information visit http://www.researchandmarkets.com/research/9j8p73/heart.

Source (News - Alert): Global Markets Direct

[ Back To Technology News's Homepage ]